Data / Form D filings / Eli Science Inc.
Eli Science Inc.: Form D filing
Eli Science Inc., a biotechnology company in Montreal, Quebec, Canada, filed a Form D with the SEC in 2025. The latest, on August 22, 2025, reports $1.1 million sold of an offering with no set size to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1001 RUE LENOIR, SUITE B520, Montreal, Quebec, Canada, H4C2Z
- Phone
- (547) 746-1492
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Quebec, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2080801
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | New notice | Indefinite | $1,064,967 | 6 | Jan 31, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Cortina | Executive Officer, Director | |
| Mona Minhas | Director | |
| Marina Pavlovic Rivas | Executive Officer, Director | |
| Assia Grazioli-Venier | Director |
Every Form D from the week of Aug 18, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Eli Science Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.